Digital Therapeutics Market by Application and End User - Global Industry Analysis and Forecast to 2025

2018-05-30 / 3800.00 / Pharma & Healthcare / 101 Pages

Description

Industry Trend Analysis

The global digital therapeutics market is estimated to be around $9 billion by 2025. The market is expected to witness high growth during forecast period due to increase in demand for digitalization of healthcare and effective management of acute and chronic diseases. Besides rise in incidences of chronic diseases, technological up gradation, demand for preventive measures for management of diseases and rising demand for e-health will further drive the market growth. Increasing use of smartphones and growing number of internet users globally will significantly contribute to the growth of the market. Another vital factor responsible for the growth of digital therapeutics market is cost effectiveness of digital therapeutics as compared to traditional methods as it allows remote consultation to patients. Despite large investment in this segment, data privacy issues, lack of awareness about digital health programs and refusal from healthcare providers as well as patients will hamper the growth of the market.

Application Outlook and Trend Analysis

Diabetes segment is expected to witness highest growth over the forecast period, due to increase in prevalence of diabetes worldwide. According to the International Diabetes Federation (IDF), around 415 million people across globe were affected by diabetes as of 2015 and this number is expected to reach 642 million by 2040. Such a high prevalence of diabetes will primarily drive growth of the market. Preventive market segment is expected to witness fastest growth during forecast period. This can be attributed to factors such as increasing demand for pre-screening techniques for various chronic diseases and rise in demand for cost saving preventive healthcare programs.

Regional Outlook and Trend Analysis

North America accounted for the largest share of the global digital therapeutics market in 2016. This can be attributed to number of factors such as rise in elderly population requiring better healthcare facilities, presence of large number of digital therapy providers in the region, high rate of adoption of advanced medical devices and rise in demand for patient-centric healthcare procedures. Europe accounted for the second largest share of the global market in 2016 due to increase demand for digitalization of healthcare.

Asia-Pacific is expected to grow at fastest CAGR during forecast period owing to a number of factors such as increase in elderly population, changing healthcare infrastructure and increase in demand for cost saving screening and treatment techniques.

Competitive Insights

Product development facilitated through technological innovation is the major strategy adopted by the key players operating in the global digital therapeutics market. For instance, in January 2017, WellDoc, Inc. obtained FDA clearance for non-prescription version of their BlueStar digital therapeutic for patients suffering from type 2 diabetes.

Some of the major players operating in the global market are Proteus Digital Health, Omada Health, Inc., WellDoc Inc., 2Morrow, Inc., Livongo Health, Propeller Health, Twinehealth, Canary Health, Inc. Mango Health, Inc. and Noom, Inc.

Market opportunities

The digital therapeutics market will be driven by technologically advanced products over the coming years as demand for patient centric healthcare is on the rise globally. Digital therapeutics facilitates the intersection of science, design and technology to create market ready solutions that provide customized healthcare programs to the patients. Such developments will fuel the growth of this market over the forecast period.

Digital Therapeutics Market Segmentation:

By Application:


Preventive



Prediabetes
Obesity



Treatment/care


o Diabetes

o Medication Adherence

o Central Nervous System Disease

o Respiratory Diseases

o Musculoskeletal Diseases

o Smoking Cessation

o Cardiovascular Diseases

o Other Applications

By End User:


Patients
Employees
Payers
Providers
Others


By Region:


North America



U.S
Canada
Mexico



Europe



Germany
France
UK
Italy
Spain
Rest of Europe



Asia-Pacific



Japan
China
Australia
India
South Korea
Rest of Asia-Pacific



Rest of the World



Brazil
South Africa
Saudi Arabia
Turkey
United Arab Emirates


o Others

Some of the key questions answered by the report are:


What was the market size in 2016 and forecast from 2017 to 2025`
What will be the industry market growth from 2017 to 2025`
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast`
What are the major segments leading the market growth and why`
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition`

Table of Content

Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Rising Prevalence of Chronic Diseases Worldwide
3.3.1.2. Rise in Demand for Preventive Measures for Disease Management
3.3.1.3. Rise in Number of Smartphones and Internet Users
3.3.2. Restraints
3.3.2.1. Resistance from Healthcare Providers
3.3.2.2. Lack of Awareness about Digital Therapeutics
3.3.2.3. Data Privacy Issues
3.3.3. Opportunities
3.3.3.1. Technological Advancements to Design and Develop Innovative Solutions
3.4. Industry Trends
4. Digital Therapeutics Market, By Application
4.1. Introduction
4.2. Digital Therapeutics Market Assessment and Forecast, By Application, 2016-2025
4.3. Preventive
4.3.1. Global Market Assessment and Forecast, By Type, 2016-2025 ($Million)
4.3.2. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.3.3. Prediabetes
4.3.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.3.4. Obesity
4.3.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.4. Treatment / Care
4.4.1. Market Assessment and Forecast, By Type, 2016-2025 ($Million)
4.4.2. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.4.3. Diabetes
4.4.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.4.4. Cardiovascular Diseases
4.4.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.4.5. Central Nervous System Disease
4.4.5.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.4.6. Smoking Cessation
4.4.6.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.4.7. Respiratory Diseases
4.4.7.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.4.8. Musculoskeletal Diseases
4.4.8.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.4.9. Smoking Cessation
4.4.9.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.4.10. Medication Adherence
4.4.10.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
4.4.11. Other Applications
4.4.11.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5. Digital Therapeutics Market, By End User
5.1. Introduction
5.2. Digital Therapeutics Market Assessment and Forecast, By End User, 2016-2025
5.2.1. Patients
5.2.1.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.2.2. Providers
5.2.2.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.2.3. Payers
5.2.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.2.4. Employees
5.2.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.2.5. Other End Users
5.2.5.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
6. Digital Therapeutics Market , By Region
6.1. Introduction
6.2. Digital Therapeutics Market Assessment and Forecast, By Region, 2016-2025 ($Million)
6.3. North America
6.3.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)
6.3.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.3.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.3.3.1. U.S.
6.3.3.1.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.3.3.1.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.3.3.2. Canada
6.3.3.2.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.3.3.2.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.3.3.3. Mexico
6.3.3.3.1. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.3.3.3.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.4. Europe
6.4.1.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)
6.4.1.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.4.1.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.4.1.4. Germany
6.4.1.4.1. Market Assessment and Forecast, By Application ,2016-2025 ($Million)
6.4.1.4.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.4.1.5. France
6.4.1.5.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.4.1.5.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.4.1.6. UK
6.4.1.6.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.4.1.6.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.4.1.7. Italy
6.4.1.7.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.4.1.7.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.4.1.8. Spain
6.4.1.8.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.4.1.8.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.4.1.9. Russia
6.4.1.9.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.4.1.9.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.4.1.10. Rest of Europe
6.4.1.10.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.4.1.10.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.5. Asia-Pacific
6.5.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)
6.5.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.5.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.5.3.1. Japan
6.5.3.1.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.5.3.1.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.5.3.2. China
6.5.3.2.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.5.3.2.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.5.3.3. Australia
6.5.3.3.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.5.3.3.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.5.3.4. India
6.5.3.4.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.5.3.4.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.5.3.5. South Korea
6.5.3.5.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.5.3.5.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.5.3.6. Taiwan
6.5.3.6.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.5.3.6.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.5.3.7. Rest of Asia-Pacific
6.5.3.7.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.5.3.7.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.6. Rest of the World
6.6.1. Market Assessment and Forecast, By Country, 2016-2025 ($Million)
6.6.2. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.6.3. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.6.3.1. Brazil
6.6.3.1.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.6.3.1.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.6.3.2. Turkey
6.6.3.2.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.6.3.2.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.6.3.3. Saudi Arabia
6.6.3.3.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.6.3.3.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.6.3.4. South Africa
6.6.3.4.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.6.3.4.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.6.3.5. United Arab Emirates
6.6.3.5.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.6.3.5.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
6.6.3.6. Others
6.6.3.6.1. Market Assessment and Forecast, By Application, 2016-2025 ($Million)
6.6.3.6.2. Market Assessment and Forecast, By End User, 2016-2025 ($Million)
7. Company Profiles
7.1. Proteus Digital Health
7.1.1. Business Overview
7.1.2. End User Portfolio
7.1.3. Strategic Developments
7.2. Omada Health, Inc.
7.2.1. Business Overview
7.2.2. End User Portfolio
7.2.3. Strategic Developments
7.3. WellDoc Inc.
7.3.1. Business Overview
7.3.2. End User Portfolio
7.3.3. Strategic Developments
7.4. 2Morrow, Inc.
7.4.1. Business Overview
7.4.2. End User Portfolio
7.4.3. Strategic Developments
7.5. Livongo Health
7.5.1. Business Overview
7.5.2. End User Portfolio
7.5.3. Strategic Developments
7.6. Propeller Health
7.6.1. Business Overview
7.6.2. End User Portfolio
7.6.3. Strategic Developments
7.7. Twinehealth
7.7.1. Business Overview
7.7.2. End User Portfolio
7.7.3. Strategic Developments
7.8. Canary Health, Inc.
7.8.1. Business Overview
7.8.2. End User Portfolio
7.8.3. Strategic Developments
7.9. Mango Health, Inc.
7.9.1. Business Overview
7.9.2. End User Portfolio
7.9.3. Strategic Developments
7.10. Noom, Inc.
7.10.1. Business Overview
7.10.2. End User Portfolio
7.10.3. Strategic Developments


Table of Figures

Table 1.Global Digital Therapeutics Market, By Application ($Million), 2016-2025
Table 2.Preventive Market, By Application ($Million), 2016-2025
Table 3.Preventive Market, By Region ($Million), 2016-2025
Table 4.Prediabetes Market, By Region ($Million), 2016-2025
Table 5.Obesity Market, By Region ($Million), 2016-2025
Table 6.Treatment / Care Market, By Application ($Million), 2016-2025
Table 7.Treatment / Care Market, By Region ($Million), 2016-2025
Table 8.Diabetes Market, By Region ($Million), 2016-2025
Table 9.Cardiovascular Diseases Market, By Region ($Million), 2016-2025
Table 10.Central Nervous System Diseases Market, By Region ($Million), 2016-2025
Table 11.Respiratory Diseases Market, By Region ($Million), 2016-2025
Table 12.Respiratory Diseases Market, By Region ($Million), 2016-2025
Table 13.Smoking Cessation Market, By Region ($Million), 2016-2025
Table 14.Medication Adherence Market, By Region ($Million), 2016-2025
Table 15.Other Applications Market, By Region ($Million), 2016-2025
Table 16.Global Digital Therapeutics Market, By End User ($Million), 2016-2025
Table 17.Patients Market, By Region ($Million), 2016-2025
Table 18.Providers Market, By Region ($Million), 2016-2025
Table 19.Payers Market, By Region ($Million), 2016-2025
Table 20.Employess Market, By Region ($Million), 2016-2025
Table 21.Other End Users Market, By Region ($Million), 2016-2025
Table 22.North America Digital Therapeutics Market, By Country, 2016-2025 ($Million)
Table 23.North America Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 24.North America Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 25.U.S. Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 26.U.S. Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 27.Canada Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 28.Canada Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 29.Mexico Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 30.Mexico Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 31.Europe Digital Therapeutics Market, By Country, 2016-2025 ($Million)
Table 32.Europe Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 33.Europe Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 34.Germany Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 35.Germany Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 36.France Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 37.France Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 38.UK Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 39.UK Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 40.Italy Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 41.Italy Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 42.Spain Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 43.Spain Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 44.Russia Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 45.Russia Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 46.Rest of Europe Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 47.Rest of Europe Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 48.Asia-Pacific Digital Therapeutics Market, By Country, 2016-2025 ($Million)
Table 49.Asia-Pacific Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 50.Asia-Pacific Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 51.Japan Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 52.Japan Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 53.China Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 54.China Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 55.Australia Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 56.Australia Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 57.India Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 58.India Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 59.South Korea Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 60.South Korea Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 61.Taiwan Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 62.Taiwan Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 63.Rest of Asia-Pacific Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 64.Rest of Asia-Pacific Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 65.Rest of the World Digital Therapeutics Market, By Country, 2016-2025 ($Million)
Table 66.Rest of the World Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 67.Rest of the World Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 68.Brazil Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 69.Brazil Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 70.Turkey Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 71.Turkey Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 72.Saudi Arabia Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 73.Saudi Arabia Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 74.South Africa Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 75.South Africa Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 76.United Arab Emirates Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 77.United Arab Emirates Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 78.Others Digital Therapeutics Market, By Application, 2016-2025 ($Million)
Table 79.Others Digital Therapeutics Market, By End User, 2016-2025 ($Million)
Table 80.Proteus Digital Health: Key Strategic Developments, 2015-2017
Table 81.Omada Health, Inc.: Key Strategic Developments, 2015-2017
Table 82.WellDoc Inc.: Key Strategic Developments, 2015-2017
Table 83.2Morrow, Inc.: Key Strategic Developments, 2015-2017
Table 84.Livongo Health: Key Strategic Developments, 2015-2017
Table 85.Propeller Health: Key Strategic Developments, 2015-2017
Table 86.Twinehealth: Key Strategic Developments, 2015-2017
Table 87.Canary Health, Inc.: Key Strategic Developments, 2015-2017
Table 88.Mango Health, Inc.: Key Strategic Developments, 2015-2017
Table 89.Noom, Inc.: Key Strategic Developments, 2015-2017

Request Sample

* mark fields are compulsory